Tower Research Capital (TRC)’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,413
Closed -$5.15K 5239
2025
Q1
$5.15K Sell
3,413
-14,506
-81% -$21.9K ﹤0.01% 4154
2024
Q4
$44.4K Sell
17,919
-3,990
-18% -$9.9K ﹤0.01% 2626
2024
Q3
$25.2K Buy
21,909
+1,843
+9% +$2.12K ﹤0.01% 3103
2024
Q2
$22.1K Buy
20,066
+14,799
+281% +$16.3K ﹤0.01% 3700
2024
Q1
$6.53K Sell
5,267
-4,477
-46% -$5.55K ﹤0.01% 4353
2023
Q4
$10.2K Buy
9,744
+5,480
+129% +$5.75K ﹤0.01% 4273
2023
Q3
$29.2K Buy
4,264
+3,056
+253% +$20.9K ﹤0.01% 3046
2023
Q2
$12.5K Sell
1,208
-870
-42% -$9.02K ﹤0.01% 3838
2023
Q1
$17K Buy
2,078
+1,438
+225% +$11.8K ﹤0.01% 3607
2022
Q4
$10K Sell
640
-7,291
-92% -$114K ﹤0.01% 3938
2022
Q3
$125K Sell
7,931
-5,269
-40% -$83K ﹤0.01% 2366
2022
Q2
$184K Buy
13,200
+11,900
+915% +$166K ﹤0.01% 1817
2022
Q1
$22K Sell
1,300
-151
-10% -$2.56K ﹤0.01% 3421
2021
Q4
$22K Sell
1,451
-5,219
-78% -$79.1K ﹤0.01% 3542
2021
Q3
$120K Sell
6,670
-1,787
-21% -$32.2K ﹤0.01% 2232
2021
Q2
$149K Buy
8,457
+7,766
+1,124% +$137K ﹤0.01% 2132
2021
Q1
$17K Buy
691
+418
+153% +$10.3K ﹤0.01% 3989
2020
Q4
$2K Buy
+273
New +$2K ﹤0.01% 4864
2020
Q1
Sell
-218
Closed 2960
2019
Q4
$0 Sell
218
-5,556
-96% ﹤0.01% 3444
2019
Q3
$7K Buy
+5,774
New +$7K ﹤0.01% 3119
2019
Q2
Sell
-946
Closed -$6K 3592
2019
Q1
$6K Buy
+946
New +$6K ﹤0.01% 2923
2018
Q4
Sell
-464
Closed -$7K 3774
2018
Q3
$7K Buy
+464
New +$7K ﹤0.01% 2939
2018
Q1
Sell
-47
Closed -$1K 3184
2017
Q4
$1K Buy
47
+20
+74% +$426 ﹤0.01% 3314
2017
Q3
$1K Buy
+27
New +$1K ﹤0.01% 3636
2017
Q2
Sell
-87
Closed -$3K 2626
2017
Q1
$3K Buy
+87
New +$3K ﹤0.01% 2429
2016
Q3
Sell
-100
Closed -$2K 3549
2016
Q2
$2K Sell
100
-86
-46% -$1.72K ﹤0.01% 3850
2016
Q1
$4K Sell
186
-626
-77% -$13.5K ﹤0.01% 2841
2015
Q4
$22K Buy
+812
New +$22K ﹤0.01% 1188